GILD

dotpem

Is it just me or does it look like GILD is trying to find a tradeable low here? It's been performing like shit but I'm going to keep an eye on it. At some point it might want to mean revert to the 200MA.

CryptoFundManager

Reuters Adage Capital Partners GP LLC Dissolves Share Stake In Moderna, Takes In Gilead Sciences! Reuters: Germany requests 5% of EU supply of remdesivir Germany has requested around 5% of the supply of remdesivir under a six-month European Union supply deal, its health ministry said on Monday, despite criticism of the deal due to a lack of evidence about the...

Alirezaaa

on longterm logarithmic support. stochastic RSI over sold. fib retracement %61.8. all looks good longterm stock

BlockTechEv

Earlier this year there was the question : How do you invest in Coronavirus vaccine stocks? Now, we have the answer : YOU DONT. Chart looking bleak, and the support lines are weak. This could be due to a few reasons: - Lack of MAINSTREAM updates - NVAX actually has no other vaccines - Market volatility due to covid and elections - Investors are seeking less...

Qkish

We maybe have finished movement inside this monthly downward channel, which looks like a corrective channel for previous bullish impulse. Chances are we will go north from here. But if price will brake this channel downwards it may as well become ugly, and there is no support levels, I guess? Anyway, now GILD highly tightened to SNP and thus electional uncertainty.

Mauriello

NASDAQ:GILD Based on technical analysis, the idea is to go long only if the bottom support level of 60 USD will not be broken. Target prices are: 1. 68USD 2. 80 USD

KML6

Good time to buy. Currently starting a nice long Pos on GILD Slow and steady on this beast as we could always dip more. buy the dips. GL

CryptoFundManager

I also wrote on the huge upside potential of Gilead when they acquired Immunomedics for $21 billion. The acquisition expands Gilead's portfolio of treatments for various types of cancer. On 9/10/2020 Oppenheimer Brokerage Boosted Price Target to Outperform from...

WallSt007

see charts at www.tradingview.com $DGX Entry 120 Target 1 $125 Target 2 $130 Why DGX? FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use With Covid wave 2 on the rise, this could be a huge player. www.prnewswire.com What is DGX? Quest Diagnostics is an American clinical...

Dmitry_Nikolaev

GILEAD SCIENCES, D1: Support zone + 4X Divergence + Nice discount + Breakout of resistance line

WallSt007

see full chart at www.tradingview.com Gild Entry $62 area Target 1 $67 Target 2 $71 stoploss $59 Why this play? Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside. What is...

PhanTichStock_com

Disclaimer

jUiCE_Trades

TRUMP PUMP! Gild on high watch with Trump receiving REMDISIVIR treatment and Trump reporting he is feeling better and expected to be discharged and return soon. Which means we could see green market this week. GILD is at my support zone and we have a gap up to fill at $69 If we can hold above $61.62 we could see a move back up to fill that gap. Good opportunity to...

Mauriello

Based on Technical Analysis the best option is to hold and wait the end of the price retracement before going long. Trump has been treated with Gilead Sciences remdesivir.

CryptoFundManager

The acquisition will expand Gilead's portfolio of treatments for various types of cancer. The deal with Immunomedics provides Gilead (GILD) with Trodelvy, an antibody drug for advanced triple-negative breast cancer. The drug was given accelerated FDA approval in April. (Source CNN Business). Sell on 1 hour chart Buy on 7h chart Sell on 3 day chart, but a trend...

RedKTrader

we're still holding GILD and now it's making another attempt at recovering from the recent drop we need to break the $67 and stay above it for couple of sessions - with strong volume - to flag a proper recovery - the prior attempt for a breakout failed - this time there's some momentum and demand - but still light. we'll see

Dmitry_Nikolaev

GILEAD SCIENCES, daily timeframe: Support line + Side of Bollinger bands + Nice discount + Divergence + Hammer

AaronX

Hearing chatter down the grape vine about Remdesivir again, watch for the bounce back-up on GILD. This was just trading in the $80 dollar range so keep an eye out for that move on the news.